Target type: biologicalprocess
The process in which enzymes, such as aspartate aminotransferase, are enabled to move from the mitochondrial matrix into the cytosol, as part of the apoptotic process. [GOC:mah, GOC:mtg_apoptosis, PMID:9843949]
The release of matrix enzymes from mitochondria, a critical event in apoptosis and other cellular stress responses, is a tightly regulated process involving multiple mechanisms.
**1. Mitochondrial Permeability Transition Pore (mPTP) Opening:**
* The mPTP is a large, non-selective channel formed in the inner mitochondrial membrane.
* Its opening is triggered by various stressors, including oxidative stress, calcium overload, and ATP depletion.
* mPTP opening leads to the disruption of the mitochondrial membrane potential, mitochondrial swelling, and the release of matrix enzymes into the cytosol.
**2. Outer Mitochondrial Membrane (OMM) Permeabilization:**
* The OMM can be permeabilized by pro-apoptotic proteins, such as Bax and Bak, which form oligomers and create pores in the membrane.
* This process is triggered by caspase activation and other apoptotic signaling pathways.
* Permeabilization of the OMM allows the release of intermembrane space proteins, including cytochrome c, as well as matrix enzymes.
**3. Apoptosis-Inducing Factor (AIF) Release:**
* AIF is a mitochondrial protein that promotes caspase-independent apoptosis.
* It is released from the mitochondria during apoptosis and translocates to the nucleus, where it induces DNA fragmentation.
**4. Endonuclease G Release:**
* Endonuclease G is another mitochondrial protein that contributes to DNA degradation during apoptosis.
* It is released from the mitochondria and translocates to the nucleus, where it cleaves DNA.
**5. Release of Other Matrix Enzymes:**
* Besides the key enzymes involved in apoptosis, other mitochondrial matrix enzymes, such as malate dehydrogenase, aconitase, and fumarase, can also be released into the cytosol.
* These enzymes contribute to the disruption of cellular metabolism and may further amplify apoptotic signaling.
**Overall, the release of matrix enzymes from mitochondria is a complex and multifaceted process that plays a crucial role in cellular fate. It is tightly regulated and involves the interplay of various factors, including mitochondrial membrane permeability, apoptotic signaling pathways, and the activation of specific pro-apoptotic proteins.**'
"
Protein | Definition | Taxonomy |
---|---|---|
Apoptosis regulator BAX | An apoptosis regulator BAX that is encoded in the genome of human. [PRO:SY, UniProtKB:Q07812] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
vorinostat | vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL). Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME. | dicarboxylic acid diamide; hydroxamic acid | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor |
abt-737 | aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor |